ScaleReady and CTMC, a joint venture between National Resilience and MD Anderson Cancer Center, have partnered to help lessen the manufacturing barriers holding back life-saving cell and gene therapies (CGTs) from reaching more patients by integrating automation tools. The agreement will enable CTMC to strategically scale the recently completed GMP facility to drive high-throughput […]
